Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 13.70T | 13.70T | 13.37T | 13.14T | 12.16T | 11.94T |
Gross Profit | 2.82T | 3.79T | 1.92T | 10.37T | 9.59T | 9.48T |
EBITDA | 3.47T | 3.51T | 3.74T | 3.41T | 3.33T | 3.20T |
Net Income | 1.00T | 1.00T | 1.28T | 1.21T | 1.18T | 916.18B |
Balance Sheet | ||||||
Total Assets | 30.06T | 30.06T | 29.60T | 25.31T | 23.86T | 22.97T |
Cash, Cash Equivalents and Short-Term Investments | 1.00T | 1.00T | 1.05T | 892.57B | 923.00B | 977.46B |
Total Debt | 11.17T | 11.17T | 10.71T | 9.15T | 8.21T | 8.37T |
Total Liabilities | 18.72T | 18.72T | 18.71T | 15.96T | 14.84T | 14.76T |
Stockholders Equity | 10.22T | 10.22T | 9.84T | 8.56T | 8.28T | 7.56T |
Cash Flow | ||||||
Free Cash Flow | 231.74B | 231.74B | 290.15B | 409.13B | 1.25T | 1.21T |
Operating Cash Flow | 2.36T | 2.36T | 2.37T | 2.26T | 3.01T | 3.01T |
Investing Cash Flow | -2.00T | -2.00T | -1.99T | -1.74T | -1.70T | -1.42T |
Financing Cash Flow | -343.03B | -343.03B | -234.45B | -590.20B | -1.44T | -1.69T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $186.28B | 10.26 | 18.26% | 6.11% | 2.05% | 61.39% | |
81 Outperform | $125.35B | 5.61 | 25.44% | 3.77% | 2.54% | 60.53% | |
81 Outperform | $283.74B | 23.83 | 19.74% | 1.39% | 6.27% | 31.78% | |
77 Outperform | $211.51B | 16.55 | 12.12% | 3.75% | 1.46% | 0.88% | |
72 Outperform | $92.00B | 13.50 | 10.39% | 2.64% | 1.23% | -15.51% | |
68 Neutral | $59.76B | 20.64 | 14.41% | 2.67% | -0.64% | 56.92% | |
60 Neutral | $46.29B | 4.07 | -13.11% | 4.12% | 1.85% | -42.71% |